Tablet manufacturing defects are one of the most common challenges in pharmaceutical production. Even when granulation and compression are properly executed, small parameter variations can lead to serious product quality issues.

In this guide, we will understand:

• What tablet manufacturing defects are
• Types of defects (compression & coating)
• Root causes
• Step-by-step troubleshooting
• GMP preventive controls
• Real industry example

This article will help production operators, QA professionals, and students clearly understand how to control defects in real manufacturing environments.

---

What Are Tablet Manufacturing Defects?

Tablet manufacturing defects are physical or visual abnormalities observed in tablets during compression or coating stages that affect:

• Appearance
• Mechanical strength
• Stability
• Patient compliance

These defects are usually detected during In-Process Checks (IPC) or visual inspection.

Defects mainly occur during:

• Granulation
• Compression
• Coating

---

Classification of Tablet Defects

Tablet defects are broadly classified into two categories:

1️⃣ Compression Defects

Occur during the tablet compression stage.

Most compression-related defects can be prevented by controlling the parameters explained in our Tablet Compression Process Guide.

2️⃣ Coating Defects

Occur during the film or sugar coating stage.

For detailed coating parameter control, refer to our Tablet Coating Process Guide.

---

Major Compression Defects (Causes & Troubleshooting)

1. Capping

Definition:
Partial or complete separation of the top or bottom portion of a tablet.

Root Causes:

• Air entrapment in granules
• Low binder concentration
• High turret speed
• Improper granule moisture

Troubleshooting:

• Reduce compression speed
• Increase dwell time
• Optimize binder quantity
• Check granule LOD

---

2. Lamination

Definition:
Tablet splits into two or more horizontal layers.

Causes:

• Excessive compression force
• Over-dried granules
• High fines percentage

Solution:

• Adjust compression force
• Improve granule size distribution
• Reduce fines

---

3. Cracking

Definition:
Fine cracks were observed on the tablet surface.

Causes:

• Large granule size
• Rapid expansion after decompression
• Low binder

Control:

• Optimize the granulation process
• Modify formulation

---

4. Sticking

Definition:
Granules stick to punch faces.

Causes:

• High moisture
• Insufficient lubricant
• Low melting point API

Prevention:

• Adjust LOD
• Increase lubrication time
• Polish punches

---

5. Picking

Definition:
Material sticks to the punch at embossed area.

Causes:

• Excess binder
• Poor punch design
• Inadequate drying

Control:

• Improve drying
• Modify embossing depth
• Apply anti-adherent

---

Major Coating Defects

1. Blistering

Definition:
Localized detachment of film coating.

Causes:

• High drying temperature
• Rapid solvent evaporation

Control:

• Adjust the inlet temperature
• Optimize spray rate

---

2. Peeling

Definition:
The coating film peels off from the tablet surface.

Causes:

• Poor adhesion
• Improper core hardness

Control:

• Ensure correct tablet hardness
• Adjust coating formulation

---

3. Color Variation

Definition:
Uneven color distribution.

Causes:

• Improper mixing
• Spray gun blockage
• Low pan speed

Solution:

• Check spray alignment
• Maintain uniform mixing

---

Step-by-Step GMP Troubleshooting Approach

When a defect is observed:

Step 1: Stop and Inform

Inform Production & QA immediately.

Step 2: Segregate Affected Batch

Hold material to prevent mix-up.

Step 3: Review BMR & IPC Records

Check:

• Compression force
• Speed
• LOD
• Hardness
• Coating parameters

Step 4: Identify Root Cause

Use:

• Fishbone analysis
• 5 Why method

Step 5: Initiate Deviation (If Required)

If the defect exceeds the limits.

If defects exceed limits, follow the proper investigation steps described in Deviation Management in Pharmaceutical Industry.

Step 6: Implement CAPA

Prevent recurrence.

To prevent recurrence, implement corrective actions as explained in CAPA in Pharmaceutical Industry.

---

Role of IPC in Preventing Defects

In-Process Checks help detect defects early by monitoring:

• Weight variation
• Hardness
• Thickness
• Friability
• Disintegration

Strong IPC control reduces:

• Batch rejection
• Rework
• Market complaints

---

Strong monitoring, as explained in In-Process Checks (IPC) in Tablet Manufacturing helps detect defects at an early stage.

GMP Control Measures

To prevent tablet manufacturing defects:

✅ Proper equipment qualification
✅ Process validation
✅ Controlled environmental conditions
✅ Trained operators
✅ Defined SOPs
✅ Regular punch maintenance
✅ Controlled granule moisture
✅ Documented parameter ranges

Production and QA coordination is critical.

As per WHO Good Manufacturing Practices (GMP) guidelines, pharmaceutical manufacturers must establish proper process controls to ensure product quality and consistency.

---

Real Industry Example

In one manufacturing unit, frequent capping was observed during compression.

Investigation revealed:

• Granule LOD was below specification
• The compression speed was high

Corrective actions:

• Adjusted drying parameters
• Reduced turret speed
• Revised IPC frequency

Result:
Defect reduced by 95% in the next three batches.

This shows that small parameter changes can cause major quality issues.

---

Advantages of Proper Defect Control

• Reduced rejection rate
• Improved batch yield
• Strong GMP compliance
• Fewer deviations
• Better regulatory audit outcomes

---

Common Mistakes in Production

❌ Ignoring minor visual defects
❌ Increasing compression force blindly
❌ Skipping punch cleaning
❌ Poor documentation
❌ Delayed deviation reporting

These habits lead to audit observations.

Conclusion

Tablet manufacturing defects are not just visual problems — they are indicators of process variation. Most defects, like capping, lamination, sticking, and coating issues, occur due to improper control of granulation parameters, compression force, environmental conditions, or equipment maintenance.

A strong GMP system does not focus only on fixing defects — it focuses on preventing them through:

• Controlled process parameters
• Effective in-process checks (IPC)
• Proper documentation
• Timely deviation and CAPA handling
• Trained production personnel

When production and QA work together, and parameters are scientifically controlled, tablet manufacturing defects can be significantly reduced, improving batch yield, regulatory compliance, and overall product quality.

In pharmaceutical manufacturing, prevention is always better than correction.

Rank Math FAQ Block